Bodi Envi blog: Safety
Plain, sourced writing on GLP-1 treatment: what the FDA-approved labels and the trials say, what compounded medication is and is not, what things cost, and how to choose a program.
- Safety
Endometriosis and GLP-1 medications: what to know
What is and is not known about GLP-1 medications and endometriosis, the birth control warning in the labels, and how to tell symptoms apart.
- Safety
Tirzepatide, pregnancy and breastfeeding: what the label says
What the Zepbound® label says about pregnancy, birth control pills, planning a pregnancy and breastfeeding, and what to ask your provider before you start.
- Safety
Is personalized compounded tirzepatide legal in 2026?
The FDA ended the tirzepatide shortage in December 2024 and the grace periods in 2025. What changed, what is still lawful, and how to spot a program to avoid.
- Safety
Semaglutide and tirzepatide drug interactions: what the labels say
The interactions the Wegovy® and Zepbound® labels name: insulin and sulfonylureas, oral medications and slower stomach emptying, and the pill on tirzepatide.
- Safety
Compounded GLP-1 safety: what to know before you start
What "not FDA-approved" means for compounded semaglutide and tirzepatide, how 503A pharmacies are regulated, the label warnings, and how to lower your risk.
Start with an online assessment.
Answer a few questions about your health and goals. A licensed provider reviews your answers and decides whether treatment is appropriate for you.
